Design Therapeutics Inc (DSGN) — Cash Flow-to-Debt Ratio
Latest as of September 2025:
-0.93x
Design Therapeutics Inc (DSGN) has a Cash Flow-to-Debt Ratio of -0.93x as of September 2025, meaning its operating cash flow of $-11.16 Million could theoretically repay -1% of its total liabilities ($12.05 Million) in one year. See Design Therapeutics Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.93x
Operating CF / Total Liabilities
Operating Cash Flow
$-11.16 Million
USD
Total Liabilities
$12.05 Million
USD
Data as of
Sep 2025
Most recent filing
Design Therapeutics Inc Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for Design Therapeutics Inc across 6 annual periods. For the full cash flow conversion analysis, see DSGN cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Design Therapeutics Inc (2019–2024)
Year-by-year debt coverage analysis for Design Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -4.31x | $-43.10 Million | $10.00 Million | ▲ +12.0% |
| 2023 | -4.90x | $-58.56 Million | $11.96 Million | ▼ -32.0% |
| 2022 | -3.71x | $-51.32 Million | $13.83 Million | ▼ -6.5% |
| 2021 | -3.49x | $-29.38 Million | $8.43 Million | ▼ -1823.4% |
| 2020 | -0.18x | $-8.67 Million | $47.83 Million | ▼ -386.6% |
| 2019 | -0.04x | $-139.00K | $3.73 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.